-
1
-
-
0037115536
-
Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10
-
DeAngelis LM, Seiferheld W, Schold SC, et al: Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. J Clin Oncol 20:4643-4648, 2002
-
(2002)
J Clin Oncol
, vol.20
, pp. 4643-4648
-
-
DeAngelis, L.M.1
Seiferheld, W.2
Schold, S.C.3
-
2
-
-
23244442926
-
-
Shah GD, DeAngelis LM: Treatment of primary central nervous system lymphoma. Hematol Oncol Clin North Am 19:611-627, v, 2005
-
Shah GD, DeAngelis LM: Treatment of primary central nervous system lymphoma. Hematol Oncol Clin North Am 19:611-627, v, 2005
-
-
-
-
3
-
-
33750603965
-
Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma
-
Gavrilovic IT, Hormigo A, Yahalom J, et al: Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma. J Clin Oncol 24:4570-4574, 2006
-
(2006)
J Clin Oncol
, vol.24
, pp. 4570-4574
-
-
Gavrilovic, I.T.1
Hormigo, A.2
Yahalom, J.3
-
4
-
-
17144455839
-
IDEC-C2B8: Results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma
-
Maloney DG, Grillo-Lopez AJ, Bodkin DJ, et al: IDEC-C2B8: Results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma. J Clin Oncol 15:3266-3274, 1997
-
(1997)
J Clin Oncol
, vol.15
, pp. 3266-3274
-
-
Maloney, D.G.1
Grillo-Lopez, A.J.2
Bodkin, D.J.3
-
5
-
-
1842368507
-
IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma
-
Maloney DG, Grillo-Lopez AJ, White CA, et al: IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood 90:2188-2195, 1997
-
(1997)
Blood
, vol.90
, pp. 2188-2195
-
-
Maloney, D.G.1
Grillo-Lopez, A.J.2
White, C.A.3
-
6
-
-
0028127304
-
Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma
-
Maloney DG, Liles TM, Czerwinski DK, et al: Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma. Blood 84:2457-2466, 1994
-
(1994)
Blood
, vol.84
, pp. 2457-2466
-
-
Maloney, D.G.1
Liles, T.M.2
Czerwinski, D.K.3
-
7
-
-
0003301373
-
Activity of Rituximab in Primary Central Nervous System Lymphoma (PCNSL)
-
abstr 642
-
Raizer J, DeAngelis LM, Zelenetz AD, et al: Activity of Rituximab in Primary Central Nervous System Lymphoma (PCNSL). Proc Am Soc Clin Oncol 19:166a, 2000 (abstr 642)
-
(2000)
Proc Am Soc Clin Oncol
, vol.19
-
-
Raizer, J.1
DeAngelis, L.M.2
Zelenetz, A.D.3
-
8
-
-
0034000056
-
Rituximab: Active treatment of central nervous system involvement by non-Hodgkin's lymphoma?
-
Ruhstaller TW, Amsler U, Cerny T: Rituximab: Active treatment of central nervous system involvement by non-Hodgkin's lymphoma? Ann Oncol 11:374-375, 2000
-
(2000)
Ann Oncol
, vol.11
, pp. 374-375
-
-
Ruhstaller, T.W.1
Amsler, U.2
Cerny, T.3
-
10
-
-
0026653255
-
Non-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315
-
Nelson DF, Martz KL, Bonner H, et al: Non-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys 23:9-17, 1992
-
(1992)
Int J Radiat Oncol Biol Phys
, vol.23
, pp. 9-17
-
-
Nelson, D.F.1
Martz, K.L.2
Bonner, H.3
-
11
-
-
33646811123
-
HD10: Investigating reduction of combined modality treatment intensity in early stage Hodgkin's lymphoma: Interim analysis of a randomized trial of the German Hodgkin Study Group (GHSG)
-
abstr 6506, 561s
-
Diehl V, Brillant C, Engert A: HD10: Investigating reduction of combined modality treatment intensity in early stage Hodgkin's lymphoma: Interim analysis of a randomized trial of the German Hodgkin Study Group (GHSG). J Clin Oncol 23:561s, 2005 (abstr 6506)
-
(2005)
J Clin Oncol
, vol.23
-
-
Diehl, V.1
Brillant, C.2
Engert, A.3
-
12
-
-
36048991297
-
Radiation dose in non-Hodgkin's lymphoma: Preliminary results of UK NCRN randomized trial
-
suppl
-
Hoskin P: Radiation dose in non-Hodgkin's lymphoma: Preliminary results of UK NCRN randomized trial. Ann Oncol 16:v51-v53, 2005 (suppl)
-
(2005)
Ann Oncol
, vol.16
-
-
Hoskin, P.1
-
13
-
-
17544388313
-
Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease
-
Loeffler M, Diehl V, Pfreundschuh M, et al: Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease. J Clin Oncol 15:2275-2287, 1997
-
(1997)
J Clin Oncol
, vol.15
, pp. 2275-2287
-
-
Loeffler, M.1
Diehl, V.2
Pfreundschuh, M.3
-
14
-
-
24644432553
-
Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma
-
Abrey LE, Batchelor TT, Ferreri AJ, et al: Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol 23:5034-5043, 2005
-
(2005)
J Clin Oncol
, vol.23
, pp. 5034-5043
-
-
Abrey, L.E.1
Batchelor, T.T.2
Ferreri, A.J.3
-
15
-
-
34548805294
-
Phase II trial of dose-dense R-CHOP followed by risk-adapted consolidation with either ICE or ICE and ASCT, based upon the results of biopsy confirmed abnormal interim restaging PET scan, improves outcome in patients with advanced stage DLBCL
-
abstr 532
-
Moskowitz C, Hamlin PA, Horwitz SM, et al: Phase II trial of dose-dense R-CHOP followed by risk-adapted consolidation with either ICE or ICE and ASCT, based upon the results of biopsy confirmed abnormal interim restaging PET scan, improves outcome in patients with advanced stage DLBCL. Blood 108:11, 2006 (abstr 532)
-
(2006)
Blood
, vol.108
, pp. 11
-
-
Moskowitz, C.1
Hamlin, P.A.2
Horwitz, S.M.3
-
16
-
-
0030453867
-
Prolonged survival in follicular non Hodgkin's lymphoma is predicted by achievement of complete remission with initial treatment: Results of a longterm study with multivariate analysis of prognostic factors
-
Davidge-Pitts M, Dansey R, Bezwoda WR: Prolonged survival in follicular non Hodgkin's lymphoma is predicted by achievement of complete remission with initial treatment: Results of a longterm study with multivariate analysis of prognostic factors. Leuk Lymphoma 24:131-140, 1996
-
(1996)
Leuk Lymphoma
, vol.24
, pp. 131-140
-
-
Davidge-Pitts, M.1
Dansey, R.2
Bezwoda, W.R.3
-
17
-
-
0022600848
-
Chemotherapy for diffuse large-cell lymphoma: Rapidly responding patients have more durable remissions
-
Armitage JO, Weisenburger DD, Hutchins M, et al: Chemotherapy for diffuse large-cell lymphoma: Rapidly responding patients have more durable remissions. J Clin Oncol 4:160-164, 1986
-
(1986)
J Clin Oncol
, vol.4
, pp. 160-164
-
-
Armitage, J.O.1
Weisenburger, D.D.2
Hutchins, M.3
-
18
-
-
0036139049
-
Importance of radiotherapy in the outcome of patients with primary CNS lymphoma: An analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments
-
Bessell EM, Lopez-Guillermo A, Villa S, et al: Importance of radiotherapy in the outcome of patients with primary CNS lymphoma: An analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments. J Clin Oncol 20:231-236, 2002
-
(2002)
J Clin Oncol
, vol.20
, pp. 231-236
-
-
Bessell, E.M.1
Lopez-Guillermo, A.2
Villa, S.3
-
19
-
-
34247342137
-
Primary central nervous system lymphoma: The Memorial Sloan-Kettering Cancer Center prognostic model
-
Abrey LE, Ben-Porat L, Panageas KS, et al: Primary central nervous system lymphoma: The Memorial Sloan-Kettering Cancer Center prognostic model. J Clin Oncol 24:5711-5715, 2006
-
(2006)
J Clin Oncol
, vol.24
, pp. 5711-5715
-
-
Abrey, L.E.1
Ben-Porat, L.2
Panageas, K.S.3
-
20
-
-
0037445256
-
Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: A report of NABTT 96-07
-
Batchelor T, Carson K, O'Neill A, et al: Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: A report of NABTT 96-07. J Clin Oncol 21:1044-1049, 2003
-
(2003)
J Clin Oncol
, vol.21
, pp. 1044-1049
-
-
Batchelor, T.1
Carson, K.2
O'Neill, A.3
-
21
-
-
33646711027
-
MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas
-
Ferreri AJ, Dell'Oro S, Foppoli M, et al: MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas. Neurology 66:1435-1438, 2006
-
(2006)
Neurology
, vol.66
, pp. 1435-1438
-
-
Ferreri, A.J.1
Dell'Oro, S.2
Foppoli, M.3
|